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a b s t r a c t
Objectives: The association between depression and sub-clinical atherosclerosis remains unclear. By
assessing depressive symptoms only at one point in time, most previous studies have failed to ascer-
tain long-term exposure. We examined the association of long-term depressive symptoms assessed at
three time points (over 10 yrs) with a marker of sub-clinical atherosclerosis.
Methods: Participants included 454 healthy, non-medicated men and women from the Whitehall II epi-
demiological cohort without known cardiovascular disease (CVD). Depressive symptoms were assessed
at three time points (over 10 yrs) and coronary atherosclerosis was assessed at follow-up in terms of
coronary artery calciﬁcation (CAC).
Results: 18.9% of the sample reported depressive symptoms at least once during follow-up. Participants
thatwere persistently depressed had over a two-fold increased risk of detectable CAC (Agatston score >0)
(odds ratio [OR] =2.56, 95% CI, 1.14–5.78) and high CAC (Agatston score≥100) (OR=2.36, 1.04–5.35)
compared with never depressed after adjustment for age, sex, and a range of conventional cardiac risk
factors. These associations were more robust in men. Participants who were depressed on only one
occasion were not at elevated risk of CAC.
Conclusions: Persistent cognitive symptoms of depression assessed over several time points, but not on
a single occasion, are related to sub-clinical coronary atherosclerosis in men free of known CVD and
diabetes.
 . Introduction
Depressive symptoms have been consistently associated with
reater risk of coronary heart disease (CHD) [1], although it is
nclear whether depression precedes atherosclerosis. Several non-
nvasive imaging techniques can be employed to examine the
xtent of sub-clinical atherosclerosis, which begins early in life
nd precedes CHD [2]. Assessment of sub-clinical atherosclerosis
efore clinical disease is manifest helps delineate the temporal
elationship between depression and CHD. Experimental studies
n primates have demonstrated an association between depres-
ive behaviour and accelerated atherogenesis [3], but evidence on
umans is mixed.
The existing studies have generally utilised measures of carotid
ntima-media thickness (IMT), and carotid or coronary plaque
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burden (calciﬁed or non-calciﬁed) as markers of sub-clinical
atherosclerosis. In some studies depression was associated with
greater IMT [4,5], greater aortic and coronary calciﬁcations [5,6]
andgreaterprogressionof carotid IMT[7,8] andplaques [9]. Inother
studies concurrent depression has not been associatedwith carotid
IMT or carotid plaques [10], nor with coronary calciﬁcation [11,12].
Furthermore, in a recent longitudinal study changes in depressive
symptoms assessed over 15 years and history of major depression
were unrelated to carotid IMT [13].
Since atherosclerosis develops over a long period of time,
chronic or recurrent depression rather than transient symptoms
may be associated more consistently with sub-clinical atheroscle-
rosis. By assessing depressive symptoms at one point in time only,
most previous studies may have failed to ascertain such long-term
exposure.
Open access under CC BY-NC-ND license.In the present study, depressive symptoms were recorded at
three time points over the 10 years before the measurement of
sub-clinical atherosclerosis. It was therefore possible to contrast
the relationship of point estimates andpersistent depressive symp-























































of clinically relevant CAC (age and sex adjusted OR=2.46, 95%
CI, 1.12–5.42) compared with never depressed, whereas transient
depressive symptomswereunrelated toCAC (OR=1.12, 0.51–2.45).
The associations between depressive symptoms and CAC persisted
Table 1
Characteristics of the study population according to episodes of depressive symp-
toms assessed in 1997, 2001, 2002/4.
Variable None (N=368) Once (N=50) Two+ (N=36)
Age at baseline (yrs) 54.6±5.7 52.1±4.5* 51.8±3.9*
Men (%) 54.9 48.0 58.3
Education (yrs) 14.7±3.8 15.0±4.1 14.7±3.4
Current smokers (%) 9.8 10 13.9
Alcohol (units/wk) 11.4±12.0 9.3±9.6 11.4±11.6
Systolic BP (mmHg) 123.6±13.9 122.8±15.2 123.4±16.1
Body mass index (kg/m2) 25.4±3.7 25.3±4.4 25.9±3.9
Total cholesterol (mmol/L) 5.85±0.95 6.17±1.10 5.63±0.93**
HDL cholesterol (mmol/L) 1.71±0.47 1.77±0.50 1.63±0.42
LDL cholesterol (mmol/L) 3.59±0.90 3.82±0.97 3.44±0.8410 M. Hamer et al. / Athero
. Methods
.1. Participants
A sub-sample of participants from the Whitehall II epidemio-
ogical cohort [14] was recruited for the assessment of coronary
rtery calciﬁcation (CAC) in 2006 to 2008. Enrolmentwas restricted
o persons who were of white European origin, had no history or
bjective signs of CHD and no previous diagnosis or treatment for
ypertension, diabetes, inﬂammatorydiseases, or allergies. In addi-
ion, participants with major depression or taking anti-depressant
edication in the 12 months prior to the heart scan assessment
ere not eligible. From the initially invited 1169 Whitehall II par-
icipants, 27.6% were not eligible (mainly because of prescribed
edications) and 25.9% declined to take part (38.6% from lower
ork grades and 20.3% from higher grades). Thus, the study pop-
lation included 543 participants, 294 men and 249 men, aged
3–76 years. They were prohibited from using any anti-histamine
r anti-inﬂammatory medication 7 days before testing and were
escheduled if they reported colds or other infections on the day
f testing. At the time of CAC assessment 8.7% of the sample were
sing lipid-lowering medication (statins). All participants gave full
nformed consent to participate in the study and ethical approval
as obtained from the University College London committee on
he Ethics of Human Research.
.2. Depressive symptoms and health assessment
Depressive symptoms were assessed from a four-item scale
erived from the 30-item General Health Questionnaire (GHQ-30),
hich has been validated by clinical interview [15]. The items
ssessed cognitive symptoms of depression only, and caseness was
eﬁned as a sum score of four or more (range 0 to 12), based on
eceiver operator curve analyses [15]. Depressive symptoms were
ssessed at three time points before the assessment of sub-clinical
therosclerosis (1997, 2001, 2002/4).
A full health assessment according to standardised protocols
t the 2002/4 visit included anthropometric measures to deter-
ine body mass index (BMI) and a venous blood sample after at
east 5hours of fasting. Blood was analysed for C-reactive protein
CRP), which was performed using high-sensitivity ELISA (R & D
ystems, Oxford, UK) and total and high-density-lipoprotein (HDL)
holesterol (serum for lipid analyses was refrigerated at −4 ◦C and
ssayed within 72hours). LDL-cholesterol concentration was cal-
ulated using the Friedewald formula. In addition, self reported
nformation about smoking and alcohol was recorded.
.3. Assessment of coronary artery calcium
The assessment of CAC was performed in 2006–2008 using
lectronbeamcomputed tomography (GE ImatronC-150, SanFran-
isco, CA) as previously described [16]. In brief, 40 contiguous 3mm
lices were obtained during a single breath-hold starting at the
arina and proceeding to the level of the diaphragm. Scan time was
00ms/slice, synchronised to 40% of the R-R interval. Agatston and
olumetric calcium scoreswere calculated to quantify the extent of
AC by a single experienced investigator blinded to the clinical data
n an Aquarius workstation (TeraRecon Inc., San Mateo, CA). Since
alciﬁed volume was very highly correlated with Agatston score
Spearman’s r=0.99), we present data for Agatston score only..4. Statistical analysis
Participants were categorised as having no depressive symp-
oms at any time point, one episode, and two or more episodes of
epression. Because of the skewed distribution of CAC values, mul-sis 210 (2010) 209–213
tivariate logistic regression analyses were employed to examine
the association of depressive symptoms episodes with the pres-
ence of detectable CAC (Agatston score >0) and high CAC (Agatston
score≥100). This threshold was based on the St. Francis Heart
Study that demonstrated maximum sensitivity and speciﬁcity for
detecting cardiovascular events at a threshold calcium score of
greater than or equal to 100 [17]. We calculated odds ratios (OR)
and 95% conﬁdence intervals (CI) for the risk of CAC according to
depressive symptoms category, adjusting sequentially for age, sex,
education, smoking, statin medication use, alcohol, HDL- and LDL-
cholesterol, CRP, andBMI. Thismodelling strategywas employed to
examine if theassociationsbetweendepressionandatherosclerosis
were independent of behavioural and cardiovascular risk factors.
All analyses were conducted using SPSS version 15.
3. Results
Of the 543 participants, 60 individuals had missing data on
depressive symptoms at one or more time points and a further 29
participants hadmissing clinical data. Theywere excluded from the
analysis. There were no differences in demographic characteristics
of thoseparticipants includedandexcluded fromthepresent analy-
ses. In the remaining sample of 454participantswith complete data
on CAC, 18.9% reported depressive symptoms at least once and the
remainder did not meet the threshold for depression on any of the
three occasions. There were no notable differences in characteris-
tics of the participants in relation to depressive symptoms, apart
from the younger age of depressed (Table 1).
Clinically relevant levels of CAC (Agatston score≥100) were
detected in 25.3% of the sample (36.4% men, 12.1% women), and
CAC was not detectable in 43% of participants (29.1% men, 59.4%
women). In Table 2a, persistent depression was associated with
higher risk of detectable CAC (Agatston score >0) in age and sex
adjusted analyses (OR=2.40, 1.09–5.29), which remained signif-
icant after further adjustments for education, smoking, alcohol,
statin medication use and traditional cardiovascular risk factors
(OR=2.56, 1.14–5.78). This pattern of results was observed in
both men and women although the point estimates did not reach
conventional levels of statistical signiﬁcance in the sex stratiﬁed
analyses (see Table 2a).
In Table 2b, we present results for depression and clinically
relevant levels of CAC (Agatston score≥100). Participants who
were persistently depressed had over a two-fold increased riskTriglycerides (mmol/L) 1.19±0.59 1.27±0.66 1.19±0.57
C-reactive protein (mg/L) 1.52±2.01 1.68±2.43 2.01±2.36
Statin medication use (%) 8.4 10.0 11.1
* p<0.05 compared with never depressed.
** p<0.05 compared with once depressed.
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Table 2a
Persistent depressive symptoms and risk of detectable coronary artery calciﬁcation (Agatston score >0).
Depression incidence Cases/N Age adjusted OR (95% CI) Model 1 OR (95% CI) Model 2 OR (95% CI)
Alla
Never 204/368 1.00 1.00 1.00
Once 30/50 1.70 (0.89–3.25) 1.65 (0.86–3.18) 1.61 (0.83–3.12)
Twice or more 25/36 2.40 (1.09–5.29) 2.37 (1.07–5.26) 2.56 (1.14–5.78)
p-trend 0.038 0.047 0.040
Women
Never 66/166 1.00 1.00 1.00
Once 10/26 1.12 (0.47–2.69) 1.17 (0.48–2.83) 1.05 (0.42–2.63)
Twice or more 8/15 2.22 (0.75–6.61) 2.40 (0.79–7.28) 2.54 (0.83–7.82)
p-trend 0.355 0.301 0.263
Men
Never 138/202 1.00 1.00 1.00
Once 20/24 3.14 (1.01–9.78) 3.01 (0.96–9.43) 3.09 (0.97–9.83)
Twice or more 17/21 2.59 (0.82–8.16) 2.54 (0.80–8.07) 2.55 (0.76–8.59)
p-trend 0.050 0.060 0.068
Model 1: with further adjustment for education, smoking, alcohol.
Model 2: with further adjustment for systolic blood pressure, HDL and LDL cholesterol, CRP, BMI, statins medication.
a All analyses contain additional adjustment for sex.
Table 2b
Persistent depressive symptoms and risk of clinically relevant coronary artery calciﬁcation (Agatston score≥100).
Depression incidence Cases/N Age adjusted OR (95% CI) Model 1 OR (95% CI) Model 2 OR (95% CI)
Alla
Never 92/368 1.00 1.00 1.00
Once 10/50 1.12 (0.51–2.45) 1.11 (0.50–2.45) 1.02 (0.47–2.25)
Twice or more 13/36 2.46 (1.12–5.42) 2.44 (1.10–5.41) 2.36 (1.04–5.35)
p-trend 0.082 0.089 0.122
Women
Never 22/166 1.00 1.00 1.00
Once 2/26 0.65 (0.14–3.01) 0.53 (0.11–2.56) 0.53 (0.10–2.73)
Twice or more 1/15 0.60 (0.07–4.90) 0.54 (0.06–4.55) 0.49 (0.05–4.61)
p-trend 0.782 0.647 0.464
Men
Never 70/202 1.00 1.00 1.00
Once 8/24 1.42 (0.55–3.67) 1.46 (0.56–3.81) 1.34 (0.50–3.61)




















Model 1: with further adjustment for education, smokin
Model 2: with further adjustment for systolic blood pres
a All analyses contain additional adjustment for sex.
n the fully adjusted model (OR=2.36, 1.04–5.35). In further anal-
ses stratiﬁed by sex, the association was only observed in men
ut not in women for whom the numbers of signiﬁcant CAC cases
ere smaller (p [for sex interaction] =0.01, Table2b). Inpersistently
epressed men there was over a three-fold increased risk of CAC
fully adjusted OR=3.87, 95% CI, 1.41–10.61) compared with men
ithout any depression.
. Discussion
The present study examined the association between long-term
epressive symptoms assessed at three time points with mea-
ures of coronary atherosclerosis. The results show that persistent
epressive symptoms were associated with CAC in men although
articipants reporting depressive symptoms only at one time point
ere not at elevated risk of CAC. The ﬁndings therefore suggest its the persistence of symptoms over time that is important.
Only one previous study [13] has examined long-term depres-
ive symptoms assessed at different time points and they observed
o association between persistent depression and carotid IMT. We
id, however, observe associations for CAC. The reason why per-0.021 0.031
hol.
DL and LDL cholesterol, CRP, BMI, statins medication.
sistent depression is related to CAC but not IMT remains unclear.
Some evidence has suggested that carotid IMT reﬂects an adap-
tive response of the vessel wall to changes in shear and tensile
stress rather than atherosclerosis [18]. Studies that have examined
associations between CAC and IMT have reported mixed ﬁndings,
with some showing strong-graded associations [19] while others
have demonstrated that there is a potential for misclassiﬁcation
from using different measures [20,21]. In addition, it is thought
that CAC is a more reliable predictor of subsequent CHD events
than carotid IMT [22,23]. Thus, the lack of associations between
depressive symptoms and carotid IMT might be because measures
of extracoronary atherosclerosis do not accurately reﬂect coronary
atherosclerosis. It is also possible that the underlying pathology
linking depression with cardiovascular disease (CVD) is speciﬁc
to the coronary vessels. However, arguing against this interpreta-
tion is evidence linking depression with higher incidence of stroke
[24,25]. The present study therefore demonstrates the importance
of taking repeated measures of depression over time and suggests
that different assessments of atherosclerosis might partly account
for inconsistencies in the existing literature.
We observed considerable sex differences in the association
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ver, limited by the lower prevalence of CAC in women and small
umbers of participants in depressed groups. These ﬁndings should
herefore be replicated in further studies. Some previous evidence
as suggested that CAC is a stronger predictor for CHD events than
onventional risk factors in men whereas this relation is less pro-
ounced in women [26]. Thus if CAC does not reﬂect risk to the
ame extent in women, this might partly explain why depression
as associated with CAC only in men.
Several pathophysiological processes, such as inﬂammation,
aemostasis, altered metabolic and cardiac autonomic control,
ight play an intermediate role in the causal pathway linking
epression and coronary atherosclerosis [27]. In a recent study,
diposity appeared to partly mediate the association between
epression and CAC in women [28] and other work suggests that
ealth behaviours play a role in the depression-CVD risk link [29].
n the present sample, however, there were no signiﬁcant differ-
nces in health behaviours, blood pressure, lipids, adiposity, or CRP
etween depressed and non-depressed participants. This might be
ecause we speciﬁcally recruited participants that were healthy
nd without history of major depression or objective signs of CHD
nd no previous diagnosis or treatment for hypertension, diabetes,
nﬂammatory diseases. In addition, the present sample of partici-
antswas originally recruited from the British civil service andmay
ot be representative of the general population.
Several limitations should be addressed. Ourmeasure of depres-
ion assessed cognitive symptomsonly. Given that previous studies
uggest that somatic symptoms of depression might better pre-
ict CHD events [30,31], the assessment of different dimensions of
epression in the present study may have strengthened our ﬁnd-
ngs. We did not obtain a measure of CAC at baseline, thus we
annot infer a longitudinal relationship between depressive symp-
oms and CAC with certainty, since this association might merely
eﬂect differences already present at baseline. Therefore, we can-
ot rule out the possibility of reverse causality that presence of CAC
ight partly drive depressive symptoms. However, given that the
articipants were healthy at the time of the heart scan it is unlikely
hat signiﬁcant CAC was present at baseline (10 yrs earlier). Lastly,
he study was limited to white European participants without his-
ory of known CVD and diabetes, thus the resultsmay not therefore
eneralise to the wider population since the presence and extent
f CAC varies among different racial groups [32].
In conclusion, persistent cognitive symptoms of depression
ssessed over several time points, but not on a single occasion,
re related to sub-clinical coronary atherosclerosis in men free of
nown CVD and diabetes.
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